Bruker Launches Unique LiquidArray® Multiplex PCR Assays

New FluoroType® Mycobacteria PCR assay detects the mycobacteria complex and differentiates 32 clinically relevant mycobacteria species from culture, using LiquidArray® multiplex PCR technology* New FluoroType® STI PCR assay detects seven major pathogens causing Sexually Transmitted Infections (STIs), using LiquidArray® multiplex PCR technology* New MBT Compass HT IVD software provides significantly increased speed for microbial identification... Read more

Meteorite Mysteries Under the Microscope

November 30, 1954: A melon-sized black rock crashes through the roof of a farmhouse in the small township of Sylacauga, Alabama (USA), bounces off a large wooden console radio, and hits a woman by the name of Ann Hodges while she is napping on her couch, leaving her with a serious bruise. While it sounds... Read more

GE Healthcare, Elekta Collaborate to Expand Access to Precision Radiation Therapy Solutions

Chicago/Stockholm: April 5, 2022 – GE Healthcare and Elekta (EKTA-B.ST) announced today that they have signed a global commercial collaboration agreement in the field of radiation oncology, enabling the two companies to provide hospitals a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy. As hospitals increasingly seek flexible and interoperable simulation... Read more

PerkinElmer Expands Salmonella Testing Portfolio with Solus One™ Detection Kit for Pet Food

AFNOR validated, immunoassay addition accelerates results, lowers cost per sample and ease of use WHAT: PerkinElmer, Inc. a global leader committed to innovating for a healthier world, today launched a pet food testing extension to its Solus One™ Salmonella test kit, a leading, highly efficient immunoassay for the detection of Salmonella in food and environmental... Read more

Bruker Leads $46 Million New Financing Round for PrognomiQ to Advance Development of Next-Generation Multi-omics Liquid Biopsy Products for Cancer

San Mateo, Calif. – March 15, 2022 – PrognomiQ – a healthcare company focused on harnessing the power of multi-omics data to transform the detection and early treatment selection and monitoring of cancer and other complex diseases – today announced it has raised $46 million in financing led by Bruker Corporation, with participation from new... Read more

Developing Smarter Steel with Artificial Intelligence Powered Software Analysis

Steel is critical to the future success of our world. As one of the only materials to be completely reusable and recyclable, it will play an essential role in building the circular economy of the future. Steel continues to evolve, becoming smarter and increasingly sustainable. Due to its versatility, steel has undergone enormous technological advances;... Read more

Moderna and Thermo Fisher Scientific Announce Long-Term Strategic Collaboration

Agreement to leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies CAMBRIDGE, Mass., & WALTHAM, Mass.–(BUSINESS WIRE)– Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced a 15-year strategic collaboration agreement... Read more

PerkinElmer’s SIRION Biotech Teams with Centre for Genomic Regulation to Develop New Generation AAV Vectors for Type 1 and Type 2 Diabetes Gene Therapy

Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its SIRION Biotech business, a world leader in viral vector-based gene delivery technologies for gene and cell therapy and vaccine development, and the Centre for Genomic Regulation (CRG), an international... Read more